BPC-157 10mg vial

BPC-157 & TB-500

What is BPC-157?

Last updated: 29 October 2026

A synthetic 15-amino-acid peptide studied in preclinical cell-migration and angiogenesis research.

Synthetic pentadecapeptidePreclinical research
Class
Synthetic pentadecapeptide
Also known as
Body Protection Compound-157, PL 14736
Type
15-amino-acid peptide
Research stage
Mostly preclinical (cell and animal models)

01 · Classification

What it is

BPC-157 is a 15-amino-acid synthetic peptide. Its sequence is a partial sequence of a larger protein originally isolated from gastric juice.

Unlike many peptides, it is reported to be stable in gastric acid, which is why it appears in gut-related research models as well as tendon, ligament and muscle models.

02 · Mechanisms

What has been studied

  • Angiogenesis: studied for effects on new blood-vessel formation, including VEGFR2 signalling, in in-vivo models.
  • Nitric oxide system: several studies examine its interaction with NO signalling and vascular tone.
  • Fibroblast and tendon models: studied for effects on fibroblast migration and growth-factor receptor expression in tendon cell cultures.

03 · Evidence

Where the research is

Most of the published research is in rodents and cell cultures, and much of it comes from a small number of research groups. Controlled human data is very limited. Treat claims beyond the preclinical record with caution.

04 · Primary sources

Read the literature

Search the primary research record directly rather than relying on summaries, including this one.

Research use only

Supplied strictly for laboratory and educational research. Not a drug, not for human or veterinary use, and not evaluated by the FDA. This overview is not medical advice and gives no dosing or administration guidance.

← All research overviews